My latest at Seeking Alpha
Cantel Medical (CMN) April quarter results and outlook [June 9, 2013]
Cantel Medical over the last 5 years has proven to have sound management. Growth prospects now appear to be as good as ever. The infection control market is growing because of the increase in global pandemics and antibiotic-resistant bacteria. This is not a hot short-term trade, but as a long-term investment I can highly recommend it.
You can also read my detailed notes on the analyst call: